Category: Biotechnology

Mar Beer has brought a new era of development in the health care system as well as making technological advancements. Since he first ventured into the pharmaceutical business 25 years ago, he has made a lot of profit and economic growth. Marc Beer has worked as an executive for many companies over the years. Marc has worked as the CEO of ViaCell where he led the company to success. He brought up new job opportunities in the company and introduced it to the worldwide market. While operating at ViaCell, Marc Beer also held plenty of other positions for different organizations. Marc has worked with several pharmaceutical industries in coming up with new medication and doing research. Apart from ViaCell and Renovia Marc Beer has founded other institutions too, all a success. Marc Beer has been among the board of directors for various companies where he gives advice and proposes new ideas. He also carried out trade for pharmaceutical products while advertising them to both the local and global market. His latest achievement is the launch of Renovia in 2016. The company was launched to help the pharmaceutical industry; it has also developed medications for other viral diseases. Renovia has brought a lot of progress in the medical world. Marc Beer’s contribution to the health care industry is remarkable. He is a universal icon in the pharmaceutical industry.

Marc Beer’s foundation Renovia Inc. has come up with original medical products for the treatment of pelvic floor disorder. Marc Beer has invested a lot into the company and is hoping for success. The company is trying to cab the spread of the disorder by inventing new technology and new medical approaches to the disease. Renovia has come up with equipment and drugs to treat pelvic floor disorder. Medical experts say that the disorder majorly affects women and that over the years more women are constantly getting infected. Renovia launched its leading product, Leva in April 2018; it immediately became approved as a viable drug. Several health organizations chipped in to help with the treatment of pelvic floor disorder; these organizations contributed capital for the improvement of the original Leva drug and the invention of four other medicines. Marc Beer is glad and appreciative of the help that he is getting from other health care industries. He is thankful for the fact that they are working together towards one vision and that is to cure as many women as they can form pelvic floor disorder. Marc Beer during an interview said that combining Renovia’s efforts with the other companies regarding technological advancements, ideas and thoughts is an excellent way of coming up with a cure. Marc Beer is also aiming at providing affordable prices to all once the product’s launch. Learn more: https://ideamensch.com/marc-beer/

The Internet of things is one of the most talked about subject in the field of technology currently. There are many people who have been commenting on the growth of the Internet of things in the recent past and how it can potentially change the technological world in the coming days. Jason Hope is one of the renowned technologist and futurist who has been discussing the various aspects of the internet of things in the last couple of years. As a futurist, Jason Hope believes that in the coming days, the existing technology would be completely replaced by the Internet of Things technology, provided that the coders are able to find a way to ensure IoT is hack free.

Jason Hope is a serial entrepreneur and has contributed massively to the various charities as well to empower local communities and people in need. He also donates to various research foundations, including the SENs Research Foundation, which has been putting in a lot of effort to forward their research on anti-aging. Jason Hope knows that with the help of proper research in the right direction, it is possible to reverse the process of aging. SENS Research Foundation has been doing research in this direction and believes that in the coming days, there would be positive results available. Jason Hope is based in Arizona and is also well-connected politically. He has done graduation in finance from the Arizona State University and MBA from the WP Carey School of Business. After completing his education, he has started a series of companies that went on to achieve considerable success.

Marc Beer is the CEO of Renovia. He has worked for over twenty years in the commercialization and developments in the fields of pharmaceuticals, biotechnology, diagnostics, and devices as well. He founded Renovia with two people, Yolanda Lorie, and Ramon Iglesias. Part of their successful business ventures includes financing with some of the global leading healthcare venture firms.

Prior to joining Renovia, Mr. Beer obtained a lot of experience in the field of healthcare that includes being the CEO of another pharmaceutical company. The goal of Renovia is to create and develop new and original treatment therapies for all of their clients around the globe. Their main focus is to help people that have rare and debilitating diseases.

Mr. Beer has held other positions before he came to work at Renovia. He was the CEO of Viatech in 2010-2017. This company was also a biotech company that specialized in the preservation, collection, and development of umbilical cords blood stem cell. While he was the CEO of Viatech, he served as an active member of the board of directors of Erynteck Pharma. Prior to coming to work for Viacell, Mr. Beer also worked in a lot of different roles for the company Genzyme. His last and most important job in that company was vice president of global marketing.

Mark Beer also served in marketing and sales roles at Abbott Laboratories. He was also a member of the Mass Life Science Board of the Massachusetts Commonwealth. Another role that he had was chairman of the board of Good Start Genetics as well as serving on their compensation committee. He graduated from the University of Miami where he got a Bachelor of Science degree.

The company that Mr. Beer is the present CEO of, Renovia is a company that is dedicated to delivering and discovering first line digital therapy and digital devices for women that have pelvic floor disorders such as urinary incontinence. In August of this year, they shared that they obtained $42.3 million in financing that includes $32.3 million in Series B equity and $10 million in venture debt. The money that was obtained will be used to pay for Renovia’s clinical trials, product development pipeline, corporate development, and their future commercial plans.

The Series B financing was led by Perceptive Advisors and Ascension Ventures, with many other companies participating as well. BayCross Capital Group helped Renovia with guidance in this project as well.

Renovia was created to commercialize and develop products for improving the first-line diagnoses and treatment to improve the condition-specific quality of life for women that have pelvic floor disorders. Their technologies make it possible for treatment via precise visualization of pelvic movement in a real-time when they train their pelvic muscles to get stronger while they watch the usage and improvement over a period of time. As a women’s health organization Renovia is searching for scalable and affordable care for pelvic floor disorders through the power of digital health. Renovia is a company that wants to help women with problems like urinary incontinence that can seriously affect them living a regular life. They strive to help woman work towards good health at a price that they can afford. Learn more: https://renoviainc.com/leadership/

Marc Beer has more than 25 years of commercialization and development experience in the field of pharmaceuticals, devices, biotechnology, and diagnostics. He founded Renovia Company together with Ramon Iglesias, Yolanda Lorie and MD in the year 2016. The company successfully closed its series of financing with the topmost healthcare venture funds. In the year 200, Mark Beer became the Chief Executive Officer of the ViaCell. The company is a biotechnology firm that specializes in the development, preservation and the collection of the umbilical cord blood stem cell.

For the past seven years, he has led the firm from its inception to a robust and rapidly growing commercial company. Under his leadership as the CEO, the organization went public in the year 2005 and grew with over 300 employees. In addition to serving as the Chief Executive Officer of the company, he also served as a member of the biopharmaceutical organization and the board of directors of the Erytech Pharma.

Marc Beer is a graduate of Miami University, Oxford, OH. In his career, he held various career positions within a specialty care firm that is committed to improving treatments of the debilitating body issues that are difficult to treat and diagnose. The most recent position that he has held is the deputy president of the Global Marketing where Marc Beer was responsible for the launch of various firm products. Its main objective was to address the rare disease populations on the world scale. He was also the founding Chairperson of the board of directors and the compensation board of Good Start Genetics.

Marc Beer’s Support for the Women Health Startup

Marc Beer recently raised approximately $42M to fund and support the women’s startup Renovia Inc. The organization offers therapeutic and diagnostic devices for the treatment of various pelvic floor disorders. This funding will help in the development and the testing of four major new products. The organization is developing multiple therapeutic and diagnostic products to treat diseases such as urinary incontinence that will help over 250 million women in the world.

The Longwood support which is a healthcare-centered investment firm that had earlier invested in Renovia, collaborated with the Series B Round to develop and test for diagnostic products which include the current generation of the Leva product. During the funding, Mark Beer said that the organization is excited to have the full support of the company financiers of the organization. He also said that the investors are willing to share the vision of the organization to treat, diagnose and improve the lives of millions of women in the world. Learn more : https://www.slideshare.net/MarcBeer